Table 1 Patients’ characteristics
Variables | Olanexidine group (n = 194) | Chlorhexidine group (n = 178) | p value |
|---|---|---|---|
Age (mean ± S.D.) | 68.5 ± 4.4 | 67.6 ± 5.9 | 0.21 |
Gender (M:F) | 158:36 | 151:27 | 0.38 |
Body Mass Index (mean ± S.D.) | 21.5 ± 2.6 | 21.7 ± 2.8 | 0.55 |
ASA Grade | 0.39 | ||
Grade 1 | 78 | 64 | |
Grade 2 | 116 | 114 | |
Pre-operative treatment | 0.43 | ||
Chemotherapy | 95 | 92 | |
Chemo-radiation | 17 | 12 | |
Clinical stage (UICC 7th) | 0.65 | ||
Stage I | 47 | 51 | |
Stage II | 49 | 48 | |
Stage III | 77 | 68 | |
Stage IV | 17 | 11 |